FDA guidelines – Page 50

Addressing Residual Solvent Build-Up in Coating Machines for Sustained Release Tablets

Addressing Residual Solvent Build-Up in Coating Machines for Sustained Release Tablets Addressing Residual Solvent Build-Up in Coating Machines for Sustained Release Tablets Introduction: In the pharmaceutical industry, producing high-quality sustained…

Challenges in validating equipment used for delayed-release capsule coating.

Challenges in validating equipment used for delayed-release capsule coating. Challenges in validating equipment used for delayed-release capsule coating. Introduction: In the pharmaceutical industry, delayed-release capsule coating is crucial for ensuring…

Validating Water Circulation Systems for Fluid Bed Granulators

Validating Water Circulation Systems for Fluid Bed Granulators Validating Water Circulation Systems for Fluid Bed Granulators Introduction: The fluid bed granulator is a critical piece of equipment in pharmaceutical manufacturing,…

Addressing Failures in Adhesion Tests for Enteric-Coated Tablets

Addressing Failures in Adhesion Tests for Enteric-Coated Tablets Addressing Failures in Adhesion Tests for Enteric-Coated Tablets Introduction: Enteric-coated tablets have revolutionized the pharmaceutical industry by providing a targeted delivery system…

Ensuring Compliance with Regulatory Standards for Clean Steam Quality

Ensuring Compliance with Regulatory Standards for Clean Steam Quality Ensuring Compliance with Regulatory Standards for Clean Steam Quality Introduction: In the pharmaceutical industry, clean steam is a critical component used…

Poor reproducibility in validation results for air filtration systems.

Poor reproducibility in validation results for air filtration systems. Poor reproducibility in validation results for air filtration systems. Introduction: In the pharmaceutical industry, air filtration systems are crucial for maintaining…

Addressing Cross-Contamination Risks in Shared Utility Lines for Coated Tablets

Addressing Cross-Contamination Risks in Shared Utility Lines for Coated Tablets Addressing Cross-Contamination Risks in Shared Utility Lines for Coated Tablets Introduction: In the pharmaceutical industry, maintaining product integrity and patient…

Validating Cleaning Procedures for High-Shear Mixers in Multi-API Tablet Production

Validating Cleaning Procedures for High-Shear Mixers in Multi-API Tablet Production Validating Cleaning Procedures for High-Shear Mixers in Multi-API Tablet Production Introduction: In the pharmaceutical industry, ensuring the cleanliness of manufacturing…

Addressing Non-Uniform Coating Thickness in Sugar-Coated Tablets

Addressing Non-Uniform Coating Thickness in Sugar-Coated Tablets Addressing Non-Uniform Coating Thickness in Sugar-Coated Tablets Introduction: Sugar-coated tablets are a time-tested pharmaceutical dosage form, favored for their aesthetic appeal, masking of…

Ensuring Robustness in Utility Validation for High-Speed Compression Equipment

Ensuring Robustness in Utility Validation for High-Speed Compression Equipment Ensuring Robustness in Utility Validation for High-Speed Compression Equipment Introduction: In the pharmaceutical industry, the production of solid dosage forms, particularly…

Challenges in validating capsule sealing for capsules with modified-release coatings.

Challenges in validating capsule sealing for capsules with modified-release coatings. Challenges in validating capsule sealing for capsules with modified-release coatings Introduction: In the pharmaceutical industry, capsules remain a popular dosage…

Validating Residual Solvent Control Measures in Coated Tablets

Validating Residual Solvent Control Measures in Coated Tablets Validating Residual Solvent Control Measures in Coated Tablets Introduction: Residual solvents are volatile chemicals used or produced in the manufacture of pharmaceutical…